Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Ironwood Pharmaceuticals Inc shares valued at $1,105 were sold by Gaskins Tammi L on Aug 11 ’25. At $0.84 per share, Gaskins Tammi L sold 1,316 shares. The insider’s holdings dropped to 241,280 shares worth approximately $0.32 million following the completion of this transaction.
Also, John Minardo sold 7,754 shares, netting a total of over 6,513 in proceeds. Following the sale of shares at $0.84 each, the insider now holds 400,378 shares.
Before that, Martini Gregory S. had sold 1,265 shares from its account. In a trade valued at $1,063, the Chief Financial Officer traded Ironwood Pharmaceuticals Inc shares for $0.84 each. Upon closing the transaction, the insider’s holdings decreased to 1,265 shares, worth approximately $0.24 million.
As published in a research note from Wells Fargo on April 15, 2025, Ironwood Pharmaceuticals Inc [IRWD] has been rated down from an Overweight to an Equal weight. Analysts at Jefferies downgraded the stock from ‘”a Buy”‘ to ‘”a Hold”‘ outlook in a report released in mid April. As of April 14, 2025, Citizens JMP has decreased its “Mkt outperform” rating to a “Mkt perform” for IRWD. Earlier on September 09, 2024, Leerink Partners initiated its rating. Their recommendation was “a Market perform” for IRWD stock.
Analyzing IRWD Stock Performance
On last trading session, Ironwood Pharmaceuticals Inc [NASDAQ: IRWD] rose 4.76% to $1.32. The stock’s lowest price that day was $1.28, but it reached a high of $1.37 in the same session. During the last five days, there has been a surge of approximately 11.86%. Over the course of the year, Ironwood Pharmaceuticals Inc shares have dropped approximately -73.81%. Shares of the company reached a 52-week high of $4.7750 on 01/07/25 and a 52-week low of $0.5271 on 05/16/25.
Support And Resistance Levels for Ironwood Pharmaceuticals Inc (IRWD)
According to the 24-hour chart, there is a support level at 1.2767, which, if violated, would cause prices to drop to 1.2333. In the upper region, resistance lies at 1.3667. The next price resistance is at 1.4133. RSI (Relative Strength Index) is 73.53 on the 14-day chart, showing overbought technical sentiment.
Is Ironwood Pharmaceuticals Inc subject to short interest?
Stocks of Ironwood Pharmaceuticals Inc saw a sharp steep in short interest on 2025-08-15 dropping by -0.46 million shares to 6.07 million. Data from Yahoo Finance shows that the short interest on 2025-07-15 was 6.53 million shares. A decline of -7.52% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.1 of the overall float, the days-to-cover ratio (short ratio) decline to 4.1.
Which companies own the most shares of Ironwood Pharmaceuticals Inc (IRWD)?
In terms of Ironwood Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 1 in the next 12 months, down nearly -20.63% from the previous closing price of $1.26. Analysts anticipate Ironwood Pharmaceuticals Inc stock to reach 1 by 2025, with the lowest price target being 1. In spite of this, 2 analysts ranked Ironwood Pharmaceuticals Inc stock as Buy at the end of 2025. On August 08, 2024, CapitalOne assigned a price target of “an Equal weight” to the stock and downgraded coverage with a $4.
